Skip to main content

Table 3 Results of QSAR overlap and molecules obtained through ADME and ADMETLAB with IC50 of confirmatory drugs

From: Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

No

Molecule ID

pIC50 (nM)

1

Ponatininb

− 0.97313

2

Pemigatinib

− 1.99957

3

Infigratinib

0.154902

4

Nintedanib

− 2.03342

5

ZINC09045651

0.72049

6

ZINC08433190

0.51368

7

NSC120289

0.08396

8

ZINC00702764

0.55542

9

ZINC00710252

0.15670

10

ZINC00668789

0.38053

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us